Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Feigenbaum

Showing results (21-30 of 67) with videos related to

Pageof 7
Sort By:
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
The International Journal of Neuroscience|November 1, 1982
Possible DA agonist properties of naloxoneJ Feigenbaum, J Yanai, R Blass
Life Sciences|January 1, 1996
The effect of naloxone on spontaneous and evoked dopamine release in the central and peripheral nervous systemsJ J Feigenbaum, S G Howard
British Journal of Pharmacology|November 1, 1972
Effect of adrenergic drugs on histamine forming capacity of human leucocytesE S Assem, J J Feigenbaum
Life Sciences|January 1, 1997
Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis studyJ J Feigenbaum, S G Howard
Acta Anatomica|January 1, 1982
Morphological alterations in the medial preoptic area after prenatal administration of phenobarbitalJ Yanai, M Woolf, J J Feigenbaum
Acta Anatomica|January 1, 1983
Genetic factors influencing neurosensitivity to early phenobarbital administration in miceJ Yanai, A Bergman, J J Feigenbaum
Experimental Neurology|November 1, 1982
Autoradiographic study of phenobarbital's effect on development of the central nervous systemJ Yanai, M Woolf, J J Feigenbaum
Acta Anatomica|January 1, 1982
Neuronal losses in mice following both prenatal and neonatal exposure to phenobarbitalA Bergman, J J Feigenbaum, J Yanai
Research Communications in Chemical Pathology and Pharmacology|February 1, 1983
Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activityJ Feigenbaum, J Yanai, H Klawans, et al.
Pageof 7

Showing results (21-30 of 67) with videos related to

Sort By:
Pageof 7
The International Journal of Neuroscience|November 1, 1996
Does gamma-hydroxybutyrate inhibit or stimulate central DA release?J J Feigenbaum, S G Howard
The International Journal of Neuroscience|November 1, 1982
Possible DA agonist properties of naloxoneJ Feigenbaum, J Yanai, R Blass
Life Sciences|January 1, 1996
The effect of naloxone on spontaneous and evoked dopamine release in the central and peripheral nervous systemsJ J Feigenbaum, S G Howard
British Journal of Pharmacology|November 1, 1972
Effect of adrenergic drugs on histamine forming capacity of human leucocytesE S Assem, J J Feigenbaum
Life Sciences|January 1, 1997
Effects of naloxone on amphetamine induced striatal dopamine release in vivo: a microdialysis studyJ J Feigenbaum, S G Howard
Acta Anatomica|January 1, 1982
Morphological alterations in the medial preoptic area after prenatal administration of phenobarbitalJ Yanai, M Woolf, J J Feigenbaum
Acta Anatomica|January 1, 1983
Genetic factors influencing neurosensitivity to early phenobarbital administration in miceJ Yanai, A Bergman, J J Feigenbaum
Experimental Neurology|November 1, 1982
Autoradiographic study of phenobarbital's effect on development of the central nervous systemJ Yanai, M Woolf, J J Feigenbaum
Acta Anatomica|January 1, 1982
Neuronal losses in mice following both prenatal and neonatal exposure to phenobarbitalA Bergman, J J Feigenbaum, J Yanai
Research Communications in Chemical Pathology and Pharmacology|February 1, 1983
Differential catecholamine uptake inhibition as a possible mode of action of D-amphetamine induced locomotor activityJ Feigenbaum, J Yanai, H Klawans, et al.
Pageof 7